Literature DB >> 16854613

High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.

Klaus Laimer1, Gilbert Spizzo, Guenther Gastl, Peter Obrist, Thomas Brunhuber, Dominic Fong, Verena Barbieri, Siegfried Jank, Wolfgang Doppler, Michael Rasse, Burghard Norer.   

Abstract

This retrospective study was designed to investigate the prognostic significance of EGFR overexpression in human oral squamous cell carcinoma on a long-term follow-up. EGFR expression was examined immunohistochemically on a tissue microarray (TMA) of paraffin embedded tissue specimens from 109 patients who underwent surgical treatment for squamous cell carcinoma of the oral cavity and oropharynx in the period between 1980 and 1997. High EGFR expression was found in 80 (73.42%) of the tumour samples. Kaplan-Meier curves showed that EGFR overexpression was significantly related to decreased overall survival (p=0.05). Multivariate analysis showed that EGFR overexpression is an independent prognostic marker in these patients (p=0.02, RR 3.6). These results confirm that EGFR overexpression is an independent prognostic marker in patients with squamous cell carcinoma of the oral cavity and oropharynx. The EGFR antigen represents an attractive target for targeted therapies with monoclonal antibodies or specific tyrosine-kinase inhibitors in these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854613     DOI: 10.1016/j.oraloncology.2006.02.009

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  40 in total

1.  Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.

Authors:  C K Martin; W P Dirksen; M M Carlton; L G Lanigan; S P Pillai; J L Werbeck; J K Simmons; B E Hildreth; C A London; R E Toribio; T J Rosol
Journal:  Vet Comp Oncol       Date:  2013-05-08       Impact factor: 2.613

Review 2.  Peptide carriers to the rescue: overcoming the barriers to siRNA delivery for cancer treatment.

Authors:  James C Cummings; Haiwen Zhang; Andrew Jakymiw
Journal:  Transl Res       Date:  2019-07-29       Impact factor: 7.012

3.  Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.

Authors:  Renato José Silva-Oliveira; Viviane Aline Oliveira Silva; Olga Martinho; Adriana Cruvinel-Carloni; Matias Eliseo Melendez; Marcela Nunes Rosa; Flávia Escremim de Paula; Luciano de Souza Viana; André Lopes Carvalho; Rui Manuel Reis
Journal:  Cell Oncol (Dordr)       Date:  2016-02-26       Impact factor: 6.730

4.  Odontogenic epithelium: immunolabeling of Ki-67, EGFR and survivin in pericoronal follicles, dentigerous cysts and keratocystic odontogenic tumors.

Authors:  Márcia Gaiger de Oliveira; Isabel da Silva Lauxen; Anna Cecília Moraes Chaves; Pantelis Varvaki Rados; Manoel Sant'Ana Filho
Journal:  Head Neck Pathol       Date:  2010-10-30

5.  Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: a case control study.

Authors:  Vanessa F Bernardes; Frederico O Gleber-Netto; Sílvia F Sousa; Tarcília A Silva; Maria Cássia F Aguiar
Journal:  J Exp Clin Cancer Res       Date:  2010-04-29

6.  Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma.

Authors:  Yasuko Hanabata; Yusuke Nakajima; Kei-ichi Morita; Kou Kayamori; Ken Omura
Journal:  Odontology       Date:  2011-05-24       Impact factor: 2.634

7.  Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKβ protein of the NFκB pathway.

Authors:  Victor M Duarte; Eugene Han; Mysore S Veena; Amanda Salvado; Jeffrey D Suh; Li-Jung Liang; Kym F Faull; Eri S Srivatsan; Marilene B Wang
Journal:  Mol Cancer Ther       Date:  2010-10       Impact factor: 6.261

Review 8.  Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function.

Authors:  Klaus Dittmann; Claus Mayer; H Peter Rodemann
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

9.  Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis.

Authors:  Shen Keren; Zhang Shoude; Zhao Lu; Yang Beibei
Journal:  Tumour Biol       Date:  2014-03

10.  Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.

Authors:  Gongyuan Zhang; Qiao Zhang; Qinxian Zhang; Lei Yin; Shenglei Li; Kuisheng Cheng; Yunhan Zhang; Honghui Xu; Weidong Wu
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-13       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.